Evidence map›Paper›PMID 40725116›Full record

ArticleInternational journal of molecular sciences2025

Metabolic Profiling of Distinct

Erica Cataldi-Stagetti, Nicola Rizzardi, Arianna Orsini, Bianca De Nicolo, Chiara Diquigiovanni, Luca Pincigher, Noah Moruzzi, Romana Fato, Christian Bergamini, Elena Bonora

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erica Cataldi-StagettiDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
Nicola RizzardiDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-9294-7116
Arianna OrsiniDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-0794-5755
Bianca De NicoloDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
Chiara DiquigiovanniDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-3124-6946
Luca PincigherDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0009-0002-9806-2789
Noah MoruzziDepartment of Molecular Medicine and Surgery, K1 MMK Signaltransduktion, 171 77 Stockholm, Sweden.ORCID 0000-0001-6868-1488
Romana FatoDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-8945-6826
Christian BergaminiDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-4387-5117
Elena BonoraDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.

Funding

Italian Ministry of University RFO2024
6 · The paper itself

Abstract

Esophageal adenocarcinoma (EAC) is a highly aggressive malignancy with rising incidence and poor prognosis.

Indexed as

AdenocarcinomaEnergy MetabolismEsophageal NeoplasmsMetabolomeMutationTumor Suppressor Protein p53Cell Line, TumorCell ProliferationGlycolysisHumansMetabolomicsOxidative PhosphorylationReactive Oxygen SpeciesReactive Oxygen SpeciesTP53 protein, humanTumor Suppressor Protein p53esophageal adenocarcinomametabolismmitochondriaTP53

Identifiers

PMID40725116
PMCPMC12295312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.